The antidiabetic drug semaglutide, also known as Ozempic, has a positive effect on patients with chronic kidney damage and obesity. They have less protein in their urine, less kidney inflammation and lower blood pressure. This was demonstrated in an international study led by clinical pharmacologist Hiddo L. Heerspink from the University Medical Center Groningen in […]